Artelo Biosciences (ARTL) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of directors, auditors, and legal counsel present virtually.

• Outlined the agenda: formal business, voting on proposals, and a Q&A session.

• Inspector of Election and meeting procedures were introduced, confirming compliance with bylaws and Nevada law.

Board and executive committee updates

• Three Class III director nominees—Gregory R. Reyes, Tamara A. Favorito, and Gregory D. Gorgas—were nominated for re-election to serve until the 2029 Annual Meeting.

Shareholder proposals

• Proposal to elect three Class III directors for terms ending at the 2029 Annual Meeting.

• Proposal to amend articles of incorporation to increase authorized common stock from 166,666,667 to 500 million.

• Proposal to approve issuance of more than 20% of outstanding common stock under an equity purchase agreement with Square Gate Capital.